Dna X (SONM) Free Cash Flow (2018 - 2025)
Dna X filings provide 8 years of Free Cash Flow readings, the most recent being -$2.0 million for Q4 2025.
- On a quarterly basis, Free Cash Flow rose 55.63% to -$2.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$23.5 million, a 170.41% decrease, with the full-year FY2025 number at -$23.5 million, down 170.41% from a year prior.
- Free Cash Flow hit -$2.0 million in Q4 2025 for Dna X, up from -$7.0 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $820000.0 in Q2 2023 to a low of -$17.6 million in Q4 2021.
- Median Free Cash Flow over the past 5 years was -$3.8 million (2023), compared with a mean of -$4.4 million.
- Biggest five-year swings in Free Cash Flow: surged 110.86% in 2022 and later tumbled 4751.52% in 2025.
- Dna X's Free Cash Flow stood at -$17.6 million in 2021, then soared by 87.35% to -$2.2 million in 2022, then surged by 83.69% to -$363000.0 in 2023, then tumbled by 1144.35% to -$4.5 million in 2024, then surged by 55.63% to -$2.0 million in 2025.
- The last three reported values for Free Cash Flow were -$2.0 million (Q4 2025), -$7.0 million (Q3 2025), and -$4.9 million (Q2 2025) per Business Quant data.